Funding Opportunities
Funding to advance therapeutic and biomarker development for Alzheimer's and related dementias
Apply Now
New Results from DIAN-TU Trial Show Drugs Failed to Slow Cognitive Decline
ADDF statement highlights the need for diverse pipeline of drugs for Alzheimer’s.
Learn More